Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years
Clinical trial NCT03587207 · COMPLETED
Trial details
- NCT number
- NCT03587207
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2018-12-19
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.